ESGCT 2025 | Asphalion

Catching up with biotech veterans at #ESGCT2025 was a real highlight! Chris Mann and Elisa Jiménez from Asphalion shared their perspectives on how cell and gene therapy have evolved, the trends shaping what’s next, and the lessons that come only with years of hands-on experience.

Tis conversation is packed with insight, stories, and practical takeaways for anyone in biotech. Watch the full interview to hear it directly from Elisa and Chris!